|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3193931 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15766120.8 |
| Date of filing the European patent application | 2015-09-15 | |
| (97) | Date of publication of the European application | 2017-07-26 |
| (45) | Date of publication and mention of the grant of the patent | 2020-08-05 |
| (46) | Date of publication of the claims translation | 2020-11-10 |
| (86) | Number | PCT/EP2015/071069 |
| Date | 2015-09-15 |
| (87) | Number | WO 2016/041945 |
| Date | 2016-03-24 |
| (30) | Number | Date | Country code |
| 201462050948 P | 2014-09-16 | US | |
| 201462083929 P | 2014-11-25 | US | |
| 201462093141 P | 2014-12-17 | US |
| (72) |
ANDRE, Pascale, FR
BLERY, Mathieu, FR
PATUREL,Carine, FR
WAGTMANN, Nicola, FR
|
| (73) |
Innate Pharma,
117, Avenue de Luminy, 13009 Marseille,
FR
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Inhibitorių kelių neutralizavimas limfocituose |
| NEUTRALIZATION OF INHIBITORY PATHWAYS IN LYMPHOCYTES |
| Payment date | Validity (years) | Amount | |
| 2024-07-24 | 10 | 231.00 EUR |
| 2025-09-15 |